![Bruce A. Freeman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bruce A. Freeman
Chief Executive Officer at Creegh Pharmaceuticals, Inc.
Bruce A. Freeman active positions
Companies | Position | Start | End |
---|---|---|---|
University of Pittsburgh | Corporate Officer/Principal | - | - |
Creegh Pharmaceuticals, Inc.
![]() Creegh Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Creegh Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Pittsburgh, PA. | Director/Board Member | - | - |
Chief Executive Officer | - | - | |
President | - | - |
Career history of Bruce A. Freeman
Former positions of Bruce A. Freeman
Companies | Position | Start | End |
---|---|---|---|
Complexa, Inc.
![]() Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Founder | 2007-12-31 | - |
Training of Bruce A. Freeman
University of California, Riverside | Doctorate Degree |
Statistics
International
United States | 5 |
Operational
Founder | 1 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sectoral
Consumer Services | 3 |
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Complexa, Inc.
![]() Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Health Technology |
Creegh Pharmaceuticals, Inc.
![]() Creegh Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Creegh Pharmaceuticals, Inc. manufactures pharmaceutical products. The company is headquartered in Pittsburgh, PA. | Health Technology |
- Stock Market
- Insiders
- Bruce A. Freeman
- Experience